DarioHealth (Nasdaq:DRIO) today announced new research demonstrating sustainably improved outcomes with its digital diabetes platform.

New York-based DarioHealth designed its digital health solutions to combine a clinically intelligent platform with consumer insights. It helps to drive sustainable behavior change to improve the management of chronic conditions, including diabetes.

The research, presented at the ADCES23 Annual Conference, produced positive results for the platform over a two-year period.

Results demonstrated 29% user engagement improvements over two years. Users with high-risk diabetes demonstrated reductions in high blood glucose reading ratios and monthly average glucose. These reductions correlated with increased engagement.

Yifat Hershcovitz, VP of clinical and scientific affairs at DarioHealth, said the solutions drive healthier behaviors and outcomes. This research provides evidence that the company’s approach to outcome-based engagement provides a long-term benefit, Hershcovitz said. The company’s members and benefits now see sustainable health improvements, according to the VP.

“Every facet of our solution is designed with one goal in mind: sustainably improving health outcomes,” Chief Medical Officer Dr. Omar Manejwala said. “This new research, like many of our studies, helps extend our understanding – and the market’s understanding – of what Dario digital health solutions are doing to achieve that goal and deliver the results our partners have come to expect.”